Not every autistic person needs this drug, but for some, it could change everything
For autistic individuals, the body's distress often speaks through the gut — bloating, constipation, and discomfort that quietly erode daily life. A small but thoughtful pilot study from the University of Missouri now suggests that propranolol, a decades-old blood pressure medication, may calm not only the nervous system but the digestive one as well, particularly for those whose bodies already carry a measure of physiological ease. The finding is less a cure than a compass, pointing medicine toward the idea that the same condition can have many inner landscapes — and that matching treatment to temperament may matter more than we once assumed.
- Autistic people suffer gastrointestinal distress at rates far above the general population, a chronic burden that medicine has struggled to adequately address.
- A 12-week study of 46 autistic teens and young adults found that propranolol — already known to reduce anxiety — also eased digestive symptoms, but only for some participants.
- The drug proved most effective for those with higher heart rate variability, suggesting that a calmer baseline nervous system is the key that unlocks the medication's benefit.
- This uneven response is not a flaw in the research but its central insight: it reframes autism treatment as a precision problem, not a one-size-fits-all prescription.
- Researchers are now developing a smartwatch application to track stress and social activity, building toward a tool that could predict who will benefit before treatment even begins.
Autistic people experience digestive problems — bloating, constipation, diarrhea — at rates that far exceed the general population, and researchers have long suspected these symptoms are entangled with the anxiety and stress that often accompany autism. A new pilot study suggests that propranolol, a common blood pressure drug already shown to reduce anxiety in autistic individuals, may also offer relief to the gut.
Brad Ferguson, an assistant research professor at the University of Missouri School of Medicine, enrolled 46 autistic teenagers and young adults in a twelve-week study at Mizzou's Thompson Center for Autism and Neurodevelopment. The results were not uniform: propranolol worked best for participants with higher heart rate variability — a physiological marker of a relatively calm nervous system. Those already in a more stressed baseline state saw less benefit.
For Ferguson, this pattern is the point. It supports a precision medicine approach — the recognition that treatments work differently depending on the individual receiving them. Not every autistic person with stomach problems needs propranolol, but for those whose digestive distress is rooted in an overactive stress response, a medication already available at any pharmacy might offer genuine relief.
The harder challenge now is identifying those people in advance. Ferguson is collaborating with an engineering colleague to build a smartwatch application that tracks stress levels and social activity, with the aim of matching patients to treatments based on their individual nervous system profiles. The study, published in the Journal of Child and Adolescent Psychopharmacology, is small — but it opens a door that precision medicine is only beginning to walk through.
Autistic people live with digestive trouble at rates that far outpace the general population. Bloating, constipation, diarrhea—these are not minor inconveniences but recurring sources of physical discomfort that shape daily life. Researchers have long suspected a connection between these stomach problems and the anxiety, stress, and depression that often accompany autism. Now a small pilot study suggests an unexpected solution: a medication that has been treating high blood pressure for decades might also quiet the gut.
Brad Ferguson, an assistant research professor at the University of Missouri School of Medicine, had already published work in 2023 showing that propranolol could reduce anxiety in autistic individuals. The drug works by blocking beta-adrenergic receptors, essentially calming the body's stress response. But Ferguson wondered if the benefits might extend further—whether easing the nervous system could also ease the stomach. He designed a new study to find out.
The research enrolled 46 autistic teenagers and young adults, all receiving care at Mizzou's Thompson Center for Autism and Neurodevelopment. Over twelve weeks, some took propranolol while others did not. The results were not uniform across the group. Instead, Ferguson found a striking pattern: the drug worked best for participants whose nervous systems were already relatively calm, measured by their heart rate variability. Those with higher heart rate variability—a physiological marker of a more relaxed baseline state—showed the most improvement in gastrointestinal symptoms. Those whose nervous systems were already in a more stressed state saw less benefit.
This distinction matters because it points toward what Ferguson calls precision medicine: the idea that treatments work differently depending on who receives them. "Our ultimate goal is to support precision medicine by finding out who can benefit from certain treatment options the most," Ferguson explains. The implication is clear—not every autistic person with stomach problems needs propranolol, but for some, it could make a real difference.
The findings raise a practical question: how do you identify which patients fall into the group most likely to benefit? Ferguson is now collaborating with Fang Wang from the College of Engineering to develop a smartwatch application that can track stress levels and social activity in autistic individuals, both those with and without gastrointestinal symptoms. The goal is to build a tool that could help clinicians match people to treatments based on their individual nervous system profiles rather than guessing.
The work appears in the Journal of Child and Adolescent Psychopharmacology, a peer-reviewed publication focused on medication outcomes in young people. It is a small study—46 participants is hardly definitive—but it opens a door. For autistic individuals whose digestive distress stems partly from an overactive stress response, a medication already on pharmacy shelves might offer relief. The next phase will be learning to predict who those people are before they start taking the drug.
Notable Quotes
Our ultimate goal is to support precision medicine by finding out who can benefit from certain treatment options the most.— Brad Ferguson, University of Missouri School of Medicine
Propranolol seemed to work best for those whose nervous system was more relaxed.— Brad Ferguson
The Hearth Conversation Another angle on the story
Why does autism come with so much stomach trouble in the first place?
The research doesn't fully explain the mechanism, but the connection seems to run through the nervous system. Autistic people often experience heightened anxiety and stress, and the gut is exquisitely sensitive to those signals. It's not that autism causes digestive disease—it's that the nervous system's state directly affects how the stomach and intestines function.
So propranolol isn't fixing the autism itself.
No. It's dampening the stress response that's making the gut worse. For some people, that's enough to break the cycle.
But Ferguson found it only works for people whose nervous systems are already calm. That seems backwards.
It does at first. But think about it this way: if your nervous system is already in overdrive, adding a drug that calms it might not be enough to overcome the damage already being done. The people who benefited most were those whose baseline was steadier—they had room for the drug to help.
So the smartwatch app is trying to identify those people before they start treatment.
Exactly. Right now, doctors would have to try propranolol and wait twelve weeks to see if it works. If they could measure heart rate variability and stress patterns beforehand, they could predict who's likely to benefit and spare others an unnecessary trial.
Is this a cure?
No. It's symptom management for a subset of autistic people. But for someone whose stomach pain is limiting their life, symptom management is meaningful.